Notting Hill, Australia
INOVIQ Ltd (ASX:IIQ) is a biotechnology company developing next-generation diagnostics and therapeutics for cancer. INOVIQ has commercialised its fast, efficient and scalable EXO-NET exosome isolation technology for biomarker discovery and diagnostics development, and the hTERT test as an adjunct test for bladder cancer. The company is advancing clinical-stage diagnostics for detection and monitoring of ovarian and breast cancers, and early-stage exosome therapeutics for solid tumours.
INOVIQ’s headquarters are based in Melbourne, Australia, and we have representation in the USA with a dedicated team of 20 employees, including 12 R&D members who collectively hold 10 PhDs. Our expertise spans research, development, clinical testing, and commercialisation.
No key contacts have been added to this profile yet.
No reviews have been added to this profile yet.
This is the company profile page for Inoviq on the Pharmaceutical Services Directory. Companies listed on the directory can update their business information free of charge. If this is your company and you'd like to claim this profile, please Contact Us.
